Oak Family Advisors, LLC Neogenomics Inc Transaction History

Oak Family Advisors, LLC

$255 Million
Q1 2024

A detailed history of Oak Family Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Oak Family Advisors, LLC holds 107,641 shares of NEO stock, worth $1.48 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

107,641

Previous 99,978 7.66%

Holding current value

$1.48 Million

Previous $1.62 Million 4.64%

% of portfolio

0.66%

Previous 0.69%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$14.06 - $16.79 $107,741 - $128,661	7,663 Added 7.66%	107,641 $1.69 Million
Q4 2023 Jan 30, 2024	BUY	$11.67 - $20.73 $37,822 - $67,185	3,241 Added 3.35%	99,978 $1.62 Million
Q3 2023 Oct 20, 2023	SELL	$12.15 - $17.85 $18,723 - $27,506	-1,541 Reduced 1.57%	96,737 $1.19 Million
Q2 2023 Aug 02, 2023	SELL	$14.1 - $19.83 $16,468 - $23,161	-1,168 Reduced 1.17%	98,278 $1.58 Million
Q1 2023 May 01, 2023	SELL	$9.09 - $19.45 $15,889 - $33,998	-1,748 Reduced 1.73%	99,446 $1.73 Million

Q4 2022 Jan 27, 2023	BUY	$6.45 - $12.07 $12,216 - $22,860	1,894 Added 1.91%	101,194 $0
Q3 2022 Nov 10, 2022	BUY	$7.86 - $12.91 $84,070 - $138,085	10,696 Added 12.07%	99,300 $855,000
Q2 2022 Jul 29, 2022	BUY	$7.06 - $13.97 $41,759 - $82,632	5,915 Added 7.15%	88,604 $722,000
Q1 2022 May 03, 2022	BUY	$12.15 - $35.28 $298,513 - $866,794	24,569 Added 42.27%	82,689 $1.01 Million
Q4 2021 Feb 02, 2022	BUY	$30.49 - $48.49 $16,921 - $26,911	555 Added 0.96%	58,120 $1.98 Million
Q3 2021 Nov 10, 2021	BUY	$41.66 - $52.52 $2.4 Million - $3.02 Million	57,565 New	57,565 $2.78 Million

Others Institutions Holding NEO

# of Institutions

281

Shares Held

128M

Call Options Held

1.13M

Put Options Held

232K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.73B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Family Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Family Advisors, LLC with notifications on news.

Account

Oak Family Advisors, LLC Neogenomics Inc Transaction History